ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 227 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $139 | -45.5% | 25,520 | -32.9% | 0.01% | -56.2% |
Q2 2023 | $255 | -67.6% | 38,058 | -63.0% | 0.03% | -59.5% |
Q4 2022 | $786 | -99.9% | 102,841 | +14.2% | 0.08% | +25.4% |
Q3 2022 | $641,000 | -6.6% | 90,025 | +428.5% | 0.06% | -18.2% |
Q1 2021 | $686,000 | – | 17,033 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Matrix Capital Management Company, LP | 15,115,090 | $419,897,000 | 10.74% |
TIGER MANAGEMENT L.L.C. | 1,115,411 | $30,986,000 | 10.41% |
Robertson Stephens Wealth Management, LLC | 537,095 | $14,920,000 | 5.10% |
VIKING GLOBAL INVESTORS LP | 33,493,708 | $930,455,000 | 4.84% |
Senator Investment Group LP | 3,388,085 | $94,121,000 | 3.41% |
Casdin Capital, LLC | 793,125 | $22,033,000 | 2.34% |
Iron Triangle Partners LP | 150,000 | $4,167,000 | 1.61% |
Aristotle Atlantic Partners, LLC | 370,841 | $10,302,000 | 1.57% |
Crewe Advisors LLC | 93,000 | $2,584,000 | 1.54% |
PERSONAL CFO SOLUTIONS, LLC | 112,916 | $3,137,000 | 1.13% |